PDF  0.51 MB  -  12 pages

The following white paper shares clinical and radiographic outcomes of the first consecutive series of THAs using the CORAIL Stem, including survival at follow-up of 20 to 25 years. The authors, therefore, aimed to update and report the clinical and radiographic outcomes of this series at a follow-up of 25 to 30 years and to calculate the survival for different endpoints of interest. This content is intended for Health Care Professionals in the United States.